CN103044549A - Preparation method of apis cerana antimicrobial peptide AccRoyalisin polyclonal antibody and use thereof - Google Patents
Preparation method of apis cerana antimicrobial peptide AccRoyalisin polyclonal antibody and use thereof Download PDFInfo
- Publication number
- CN103044549A CN103044549A CN2012105737208A CN201210573720A CN103044549A CN 103044549 A CN103044549 A CN 103044549A CN 2012105737208 A CN2012105737208 A CN 2012105737208A CN 201210573720 A CN201210573720 A CN 201210573720A CN 103044549 A CN103044549 A CN 103044549A
- Authority
- CN
- China
- Prior art keywords
- accroyalisin
- gst
- protein
- antibody
- absorbance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000044503 Antimicrobial Peptides Human genes 0.000 title claims abstract description 34
- 108700042778 Antimicrobial Peptides Proteins 0.000 title claims abstract description 34
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 241000256846 Apis cerana Species 0.000 title claims description 9
- 241000256844 Apis mellifera Species 0.000 claims abstract description 79
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 70
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 58
- 238000002835 absorbance Methods 0.000 claims abstract description 47
- 229940109850 royal jelly Drugs 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 44
- 102000036639 antigens Human genes 0.000 claims abstract description 36
- 108091007433 antigens Proteins 0.000 claims abstract description 36
- 108010027972 royalisin Proteins 0.000 claims abstract description 36
- 210000000087 hemolymph Anatomy 0.000 claims abstract description 35
- 239000000427 antigen Substances 0.000 claims abstract description 31
- 241000283973 Oryctolagus cuniculus Species 0.000 claims abstract description 12
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 10
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 5
- 241000256843 Apis mellifera ligustica Species 0.000 claims description 18
- 238000000926 separation method Methods 0.000 claims description 10
- 230000004927 fusion Effects 0.000 claims description 8
- 239000002243 precursor Substances 0.000 claims description 8
- 238000010790 dilution Methods 0.000 claims description 7
- 239000012895 dilution Substances 0.000 claims description 7
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 6
- 239000013604 expression vector Substances 0.000 claims description 5
- 241000672609 Escherichia coli BL21 Species 0.000 claims description 4
- 239000002299 complementary DNA Substances 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 3
- 241000257303 Hymenoptera Species 0.000 abstract description 42
- 241000588724 Escherichia coli Species 0.000 abstract description 8
- 208000035240 Disease Resistance Diseases 0.000 abstract description 7
- 238000001514 detection method Methods 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 238000011156 evaluation Methods 0.000 abstract 2
- 101001116000 Apis mellifera Major royal jelly protein 1 Proteins 0.000 abstract 1
- 238000009341 apiculture Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 30
- 238000010828 elution Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 239000006228 supernatant Substances 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 12
- 108020001507 fusion proteins Proteins 0.000 description 12
- 102000037865 fusion proteins Human genes 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 10
- 238000002649 immunization Methods 0.000 description 10
- 230000003053 immunization Effects 0.000 description 10
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 10
- 241000238631 Hexapoda Species 0.000 description 9
- 125000000539 amino acid group Chemical group 0.000 description 9
- 108010002069 Defensins Proteins 0.000 description 8
- 102000000541 Defensins Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 239000012148 binding buffer Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000003000 inclusion body Anatomy 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 235000012907 honey Nutrition 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000003259 recombinant expression Methods 0.000 description 5
- 241000256836 Apis Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 210000005069 ears Anatomy 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 229940049954 penicillin Drugs 0.000 description 4
- 239000012460 protein solution Substances 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000008399 tap water Substances 0.000 description 4
- 235000020679 tap water Nutrition 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- QHBZHVUGQROELI-SOFGYWHQSA-N (E)-10-hydroxydec-2-enoic acid Chemical compound OCCCCCCC\C=C\C(O)=O QHBZHVUGQROELI-SOFGYWHQSA-N 0.000 description 3
- 241000358063 Apis cerana cerana Species 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- QHBZHVUGQROELI-UHFFFAOYSA-N Royal Jelly acid Natural products OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108010077805 Bacterial Proteins Proteins 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 101001026137 Cavia porcellus Glutathione S-transferase A Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 101000870531 Pleuronectes platessa Glutathione S-transferase A Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 238000003450 affinity purification method Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 241000238876 Acari Species 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 241000179993 Apis mellifera mellifera Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- 108050004290 Cecropin Proteins 0.000 description 1
- ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000193418 Paenibacillus larvae Species 0.000 description 1
- 101710088675 Proline-rich peptide Proteins 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000012265 beta-defensin Human genes 0.000 description 1
- 108050002883 beta-defensin Proteins 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
本发明公开了一种中华蜜蜂抗菌肽AccRoyalisin多克隆抗体的制备方法及用途。以大肠杆菌重组表达的中华蜜蜂王浆抗菌肽AccRoyalisin为抗原,免疫大白兔制备的多克隆抗体,该抗体效价大于40000倍;以此多克隆抗体为一抗,以重组表达的GST-AccRoyalisin为标准蛋白抗原作倍比稀释,用酶标仪通过Elisa法检测不同浓度GST-AccRoyalisin蛋白样品的吸光度,建立吸光度与MRJP1蛋白浓度的标准曲线。将不同蜂种或不同蜂群的血淋巴、蜂王浆冻干粉稀释后作为抗原,采用Elisa法检测得到样品的吸光度,代入所建立的标准曲线,计算得到样品的Royalisin的含量。本发明为Royalisin抗体提供了一种新的用途,为养蜂领域蜂中和蜂群抗病力的评价、抗病蜂群的选育,为蜂王浆防腐抗菌性能的评价提供了一种快捷的定性定量检测新方法。The invention discloses a preparation method and application of a polyclonal antibody of the antibacterial peptide AccRoyalisin of Apis mellifera. The antimicrobial peptide AccRoyalisin of Chinese bee royal jelly recombinantly expressed in Escherichia coli was used as the antigen to immunize the polyclonal antibody prepared by white rabbits, and the antibody titer was more than 40000 times; the polyclonal antibody was used as the primary antibody, and the recombinantly expressed GST-AccRoyalisin was used as the standard The protein antigen was serially diluted, and the absorbance of different concentrations of GST-AccRoyalisin protein samples was detected by Elisa method with a microplate reader, and a standard curve was established between the absorbance and MRJP1 protein concentration. The hemolymph and royal jelly freeze-dried powder of different bee species or different bee colonies were diluted as antigens, and the absorbance of the samples was detected by Elisa method, which was substituted into the established standard curve to calculate the content of Royalisin in the samples. The present invention provides a new application for the Royalisin antibody, and provides a fast qualitative method for the evaluation of the disease resistance of bees and bee colonies in the field of beekeeping, the selection of disease-resistant bee colonies, and the evaluation of the antiseptic and antibacterial properties of royal jelly A new method for quantitative detection.
Description
技术领域 technical field
本发明涉及基因工程和免疫学领域,特别地,本发明涉及一种用中华蜜蜂(Apis cerana cerana)王浆抗菌肽AccRoyalisin基因融合表达产物GST-AccRoyalisin制备的多克隆抗体。更具体地说,本发明涉及AccRoyalisin抗体的制备方法,以及用该抗体Elisa法检测中华蜜蜂、意大利蜜蜂血淋巴中Royalisin含量,作为判断蜂种或蜂群抗病力的依据;以及用该抗体Elisa法检测蜂王浆中Royalisin含量,作为评价蜂王浆防腐性能的依据。 The invention relates to the fields of genetic engineering and immunology, in particular, the invention relates to a polyclonal antibody prepared by using the antimicrobial peptide AccRoyalisin gene fusion expression product GST-AccRoyalisin of Apis cerana cerana royal jelly. More specifically, the present invention relates to the preparation method of AccRoyalisin antibody, and using the antibody Elisa method to detect the Royalisin content in the hemolymph of Apis mellifera and Apis mellifera, as the basis for judging the disease resistance of bee species or bee colonies; and using the antibody Elisa The content of Royalisin in royal jelly was detected by this method, which was used as the basis for evaluating the antiseptic performance of royal jelly.
背景技术 Background technique
蜂王浆是蜜蜂头部王浆腺分泌的生物活性物质,具有促进人体生长发育,抗疲劳、提高免疫力、抗肿瘤、抗炎和抗菌等多种功能,作为人类的营养保健品历史悠久。Royalisin是蜂王浆中的一种抗菌肽,是蜜蜂受到微生物或其他外源有害物质侵染时由头部或胸部产生的一种低分子肽类。日本学者Fujiwara等(Fujiwara, S. et al. J. Biol. Chem., 1990, 265: 11333-11337)最初通过酸处理王浆,从王浆中分离获得了Royalisin,其分子量为5523 Da,其一级结构由51 个氨基酸残基组成,与蜜蜂血淋巴中的defensin序列几乎相同,仅第50位的氨基酸残基出现变化,由defensin中的精氨酸代替了王浆中Royalisin中的酪氨酸。Royalisin没有特异性,诱导产物不仅只对特定微生物,通常对其他微生物也有抗生作用。Bilikova和Bachanová等(Bilikova, K.,et al. Apidologie, 2001, 32 : 275-283; Bachanová, K., et al. Apidologie, 2002, 33 : 259-269.)对从天然王浆中分离的Royalisin进行相应的抑菌试验,证实该多肽对革兰氏阳性细菌蜜蜂幼腐病菌(Paenibacillus larvae larvae)有很强的抑菌作用,在低至1 μM的浓度下也具有抑菌作用;对革兰氏阳性细菌枯草芽孢杆菌(Bucillus. subtilis )和藤黄八叠球菌(Sarcina lutea),包括灰霉菌 Botrytis cinerea也有很好的抑菌作用,但对革兰氏阴性细菌无作用。 Royal jelly is a biologically active substance secreted by the royal jelly glands on the head of bees. It has many functions such as promoting human growth and development, anti-fatigue, improving immunity, anti-tumor, anti-inflammatory and antibacterial. It has a long history as a nutritional health product for human beings. Royalisin is an antimicrobial peptide in royal jelly. It is a low-molecular-weight peptide produced by the head or chest of bees when they are infected by microorganisms or other exogenous harmful substances. Japanese scholar Fujiwara et al. (Fujiwara, S. et al. J. Biol. Chem., 1990, 265: 11333-11337) initially obtained Royalisin from royal jelly by acid treatment. Its molecular weight is 5523 Da, and its primary The structure consists of 51 amino acid residues, which are almost identical to the sequence of defensin in bee hemolymph, only the 50th amino acid residue is changed, and the arginine in defensin replaces the tyrosine in royalisin in royal jelly. Royalisin has no specificity, and the induced product not only has antimicrobial effects on specific microorganisms, but also has antibacterial effects on other microorganisms. Bilikova and Bachanová et al. (Bilikova, K., et al. Apidologie, 2001, 32 : 275-283; Bachanová, K., et al. Apidologie, 2002, 33 : 259-269.) on Royalisin isolated from natural royal jelly Corresponding antibacterial tests were carried out, and it was confirmed that the polypeptide had a strong antibacterial effect on the Gram-positive bacterium Paenibacillus larvae larvae, and it also had an antibacterial effect at a concentration as low as 1 μM; Gram-positive bacteria Bacillus subtilis (Bucillus. subtilis) and lutea Sarcina lutea (Sarcina lutea), including Botrytis cinerea also have a good antibacterial effect, but have no effect on Gram-negative bacteria.
在目前全世界已报道的9个蜜蜂属(Apis)成员中,只有西方蜜蜂(Apis mellifera(其中分布最广的为意大利蜜蜂A. mellifera mellifera,简称意蜂)和东方蜜蜂(A. cerana)得到人工驯化和规模化人工养殖,并用于蜂蜜生产。相对于西方蜜蜂来说,东方蜜蜂(A.cerana),包括我国特有的亚种中华蜜蜂(A. cerana cerana,简称中蜂)因生产性能较低,蜂群数量在原产地正处于萎缩状态。但国内外研究表明,因中华蜜蜂因长期适应于我国地理气候环境,具有西方蜜蜂所不具备的抗病性、耐寒性等抗逆性能,其生物学特点也非常不同于前者,在蜜蜂育种和生态多样性保护等方面具有非常重要的利用价值。因为抗菌肽在蜜蜂的自身防御系统里起着不可替代的作用。蜂螨和近年来爆发的蜜蜂崩塌病对西方蜜蜂危害十分严重, 蜂病防治受到各国的高度重视, 很多蜜蜂专家已在选育抗病品种作为最重要的防治手段方面开展了大量研究。近年国内学者(Xu, P., et al . PLoS ONE. 2009, 4: 1-9.)研究表明,包括中华蜜蜂亚种在内的东方蜜蜂(Apis cerana)之所以抗病性优于意大利蜜蜂在内的西方蜜蜂,与其分泌抗菌肽能力强、种类多密切相关。 Among the 9 members of the genus Apis reported in the world, only Apis mellifera (A. mellifera mellifera, the most widely distributed Italian bee) and A. Artificial domestication and large-scale artificial breeding, and used for honey production.Compared with Western honeybees, Oriental honeybee ( A.cerana ), including China's unique subspecies Chinese honeybee ( A.cerana cerana, referred to as the honeybee) The number of bee colonies is shrinking in the place of origin. However, domestic and foreign studies have shown that because Chinese honeybees have long-term adaptation to China's geographical and climate environment, they have disease resistance, cold resistance and other stress resistance properties that Western honeybees do not have. The biological characteristics are also very different from the former, and it has very important value in bee breeding and ecological diversity protection. Because antimicrobial peptides play an irreplaceable role in the bee's own defense system. Bee mites and the outbreaks in recent years Bee collapse disease is very harmful to Western honeybees, and the prevention and control of bee diseases has been highly valued by various countries. Many bee experts have carried out a lot of research on the selection of disease-resistant varieties as the most important control method. In recent years, domestic scholars (Xu, P., et al . PLoS ONE. 2009, 4: 1-9.) Studies have shown that the disease resistance of oriental honeybees ( Apis cerana ), including Apis cerana subspecies, is better than that of western bees including Italian honeybees, rather than secreting antibacterial Strong peptide ability and many types are closely related.
目前国际上已发现的抗菌肽分为四大类: (a) cecropins, (b) defensins 或sapecins, (c) attacin-like proteins,(d) proline-rich peptides。Defensins是昆虫抗菌肽中最多的一类,它包括了三个亚类:精典defensins, β-defensins 和昆虫defensins。Royalisin属于昆虫 defensins亚类。昆虫 defensins亚类一般由36-51个氨基酸残基组成,三对二硫键,一个α-折叠、两个β折叠和一个N-端环组成的稳定结构,均具有抗革兰氏阳性细菌的活性 (Cho, W. L., et al Insect Biochem. Molec. Biol. 1996, 26: 395-402)。 At present, the antimicrobial peptides discovered in the world are divided into four categories: (a) cecropins, (b) defensins or sapecins, (c) attacin-like proteins, (d) proline-rich peptides. Defensins are the most numerous class of insect antimicrobial peptides, which include three subclasses: classic defensins, β-defensins and insect defensins. Royalisin belongs to the subclass of insect defensins. The insect defensins subclass generally consists of 36-51 amino acid residues, three pairs of disulfide bonds, a stable structure composed of an α-sheet, two β-sheets and an N-terminal loop, all of which have anti-gram-positive bacteria Activity (Cho, W. L., et al Insect Biochem. Molec. Biol. 1996, 26: 395-402).
中蜂与意蜂的Royalisin氨基酸组成有95%以上的同源性。目前对Royalisin,除了西方蜜蜂的Royalisin基因序列和氨基酸序列有报道,从天然王浆中分离的Royalisin进行了抑菌试验外,目前国内外尚未见利用Royalisin抗体检测蜜蜂蜂种和蜂群血淋巴中Royalisin含量,以及蜂王浆中Royalisin含量,作为评价蜂种和蜂群抗病力、蜂王浆防腐性能的依据的报道。 The amino acid composition of Royalisin between Zhongfeng and Italian bee has more than 95% homology. At present, Royalisin, in addition to reports on the Royalisin gene sequence and amino acid sequence of Apis mellifera, and the antibacterial test of Royalisin isolated from natural royal jelly, there is no use of Royalisin antibodies to detect Royalisin in bee species and bee colony hemolymph at home and abroad. content, and Royalisin content in royal jelly, as the basis for evaluating the disease resistance of bee species and bee colonies, and the antiseptic performance of royal jelly.
发明内容 Contents of the invention
本发明的目的在于针对现有技术的不足,提供一种中华蜜蜂王浆抗菌肽AccRoyalisin基因重组表达产物制备多克隆抗体的方法及用途。 The purpose of the present invention is to address the deficiencies of the prior art, and provide a method and application for preparing a polyclonal antibody from a recombinant expression product of the antibacterial peptide AccRoyalisin gene of Apis mellifera royal jelly.
本发明的目的是通过以下技术方案来实现的: The purpose of the present invention is achieved through the following technical solutions:
一种蜂王浆王浆抗菌肽AccRoyalisin抗体的制备方法,步骤如下: A preparation method of royal jelly antibacterial peptide AccRoyalisin antibody, the steps are as follows:
(1)以含中华蜜蜂王浆抗菌肽AccRoyalisin 基因的该蜂头部cDNA为模板, 用PCR 方法扩增出其前体片段, 并克隆入含GST编码基因的表达载体pGEX- 4T- 2 中,将筛选获得的重组pGEX-4T-2/ AccRoyalisin转化大肠杆菌BL21中与谷胱甘肽融合进行表达;用亲和分离方法纯化目标蛋白GST-Acc Royalisin; (1) Using the bee head cDNA containing the AccRoyalisin gene as a template, its precursor fragment was amplified by PCR, and cloned into the expression vector pGEX-4T-2 containing the GST-encoded gene. The recombinant pGEX-4T-2/AccRoyalisin obtained by screening was transformed into E. coli BL21 and expressed by fusion with glutathione; the target protein GST-AccRoyalisin was purified by affinity separation method;
(2)以纯化的GST-AccRoyalisin作为抗原,免疫大白兔,取血清获得GST-AccRoyalisin多克隆抗体。 (2) Using purified GST-AccRoyalisin as an antigen, white rabbits were immunized, and the serum was collected to obtain GST-AccRoyalisin polyclonal antibody.
所述的方法制备的GST-AccRoyalisin多克隆抗体。 The GST-AccRoyalisin polyclonal antibody prepared by the method.
所述的GST-AccRoyalisin多克隆抗体检测蜜蜂血淋巴中抗菌肽Royalisin含量的Elisa方法, The described GST-AccRoyalisin polyclonal antibody detects the Elisa method of antimicrobial peptide Royalisin content in bee hemolymph,
(1)以GST-AccRoyalisin多克隆抗体为一抗,以重组表达GST-AccRoyalisin为标准抗原蛋白作倍比稀释,用酶标仪通过Elisa法,检测不同浓度GST-AccRoyalisin蛋白样品的吸光度,建立吸光度与AccRoyalisin蛋白浓度的标准曲线; (1) Use the GST-AccRoyalisin polyclonal antibody as the primary antibody, and use the recombinant expressed GST-AccRoyalisin as the standard antigen protein for doubling dilution, and use a microplate reader to detect the absorbance of different concentrations of GST-AccRoyalisin protein samples by the Elisa method, and establish the absorbance Standard curve with AccRoyalisin protein concentration;
(2)用中华蜜蜂和意大利蜜蜂血淋巴为抗原,以GST-AccRoyalisin多克隆抗体为一抗,采用Elisa法检测获得样品的吸光度,代入所建立的标准曲线,计算得到样品的Royalisin含量。 (2) Using the hemolymph of Apis cerana and Apis mellifera as antigens and GST-AccRoyalisin polyclonal antibody as the primary antibody, the absorbance of the obtained samples was detected by Elisa method, and substituted into the established standard curve to calculate the content of Royalisin in the samples.
所述的Elisa方法应用于测定中华蜜蜂与意大利蜜蜂抗病菌能力的差异。 The described Elisa method was applied to determine the difference in the anti-bacteria ability of Apis mellifera and Apis mellifera.
所述的GST-AccRoyalisin多克隆抗体用于检测蜂王浆中抗菌肽Royalisin含量的Elisa方法, The GST-AccRoyalisin polyclonal antibody is used to detect the Elisa method of antimicrobial peptide Royalisin content in royal jelly,
(1)以GST-AccRoyalisin多克隆抗体为一抗,以重组表达的GST-AccRoyalisin为标准抗原蛋白作倍比稀释,用酶标仪通过Elisa法,检测不同浓度GST-AccRoyalisin蛋白样品的吸光度,建立吸光度与AccRoyalisin蛋白浓度的标准曲线; (1) Using the GST-AccRoyalisin polyclonal antibody as the primary antibody and the recombinantly expressed GST-AccRoyalisin as the standard antigen protein for doubling dilution, use a microplate reader to detect the absorbance of different concentrations of GST-AccRoyalisin protein samples by Elisa method, and establish Standard curve of absorbance and AccRoyalisin protein concentration;
(2)用蜂王浆冻干粉蛋白抽提物为抗原,以GST-AccRoyalisin多克隆抗体为一抗,采用Elisa法检测获得样品吸光度,代入所建立的标准曲线,计算得到样品中的Royalisin的含量。 (2) The protein extract of royal jelly freeze-dried powder was used as the antigen, the GST-AccRoyalisin polyclonal antibody was used as the primary antibody, and the absorbance of the sample was detected by Elisa method, which was substituted into the established standard curve to calculate the content of Royalisin in the sample.
所述的Elisa方法应用于测定蜂皇浆防腐性能。 The described Elisa method is applied to the determination of the antiseptic properties of royal jelly.
本发明的有益效果是: The beneficial effects of the present invention are:
(1)本发明首次用中华蜜蜂王浆抗菌肽AccRoyalisin的基因重组融合表达产物制备出效价较高的多克隆抗体。 (1) In the present invention, for the first time, a polyclonal antibody with higher titer was prepared by gene recombination and fusion expression product of antibacterial peptide AccRoyalisin of Apis mellifera royal jelly.
(2)建立以Royalisin抗菌肽作为鉴别蜂王浆真伪和质量的新指标,可填补现行蜂王浆国家标准的不足。因为现行蜂王浆国家标准(GB 9697-2008)以王浆酸10-HDA为蜂王浆的特有活性成分,也是国际贸易中衡量蜂王浆质量及真伪的关键指标。但Antinelli等(Antinelli, et al. 2003, Food Chem, 80: 85-89)研究表明:10-HDA在-18℃、4℃和室温条件下贮藏12个月,其含量分别只减少0.1%、0.2%和0.4%,非常稳定,即使在高温下也仅有少量降解。因此,不适合作为蜂王浆新鲜度以及品质的指标。 (2) The establishment of Royalisin antimicrobial peptides as a new indicator to identify the authenticity and quality of royal jelly can fill in the deficiency of the current national standard for royal jelly. Because the current national standard for royal jelly (GB 9697-2008) uses royal jelly acid 10-HDA as the unique active ingredient of royal jelly, it is also a key indicator for measuring the quality and authenticity of royal jelly in international trade. However, Antinelli et al. (Antinelli, et al. 2003, Food Chem, 80: 85-89) showed that the content of 10-HDA was only reduced by 0.1% and 0.2% and 0.4%, very stable, only a small amount of degradation even at high temperatures. Therefore, it is not suitable as an indicator of the freshness and quality of royal jelly.
(3)本发明为蜂王浆中Royalisin含量的测定提供了一种简便易行、准确度高的Elisa快速测定方法。Elisa法作为一种抗原抗体的定量分析法,由于酶的催化效率很高,可极大地放大反应效果,从而使测定方法达到很高的灵敏度。同时,该方法操作简单,方便迅速,成本低廉,用此方法检测蜂王浆质量十分可行。 (3) The present invention provides a simple and easy, high-accuracy Elisa rapid determination method for the determination of Royalisin content in royal jelly. As a quantitative analysis method of antigen and antibody, the Elisa method can greatly amplify the reaction effect due to the high catalytic efficiency of the enzyme, so that the determination method can achieve high sensitivity. At the same time, the method is simple, convenient, rapid and low in cost, and it is very feasible to use this method to detect the quality of royal jelly.
附图说明 Description of drawings
图1是AccRoyalisin基因在大肠杆菌中的融合表达产物GST-AccRoyalisin的SDS-PAGE电泳图。其中泳道1-3为阳性克隆菌液诱导产物上清(可溶性蛋白); 泳道M为蛋白标准; 泳道7-9为阳性克隆菌液诱导产物沉淀(包涵体蛋白); 泳道10: 含空表达载体的菌液诱导产物沉淀(包涵体蛋白)。GST-AccRoyalisin蛋白用箭头标出。 Figure 1 is the SDS-PAGE electrophoresis of GST-AccRoyalisin, the fusion expression product of AccRoyalisin gene in Escherichia coli. Among them, lanes 1-3 are the supernatant of the product induced by the positive clone (soluble protein); lane M is the protein standard; lanes 7-9 are the precipitate of the product induced by the positive clone (inclusion body protein); lane 10: contains the empty expression vector The bacterial solution induces product precipitation (inclusion body protein). GST-AccRoyalisin protein is marked with an arrow.
图2是通过亲和分离的重组融合表达产物GST-AccRoyalisin的SDS-PAGE电泳图。其中泳道M为蛋白标准,泳道M为蛋白标准,泳道3-7为纯化得到的洗脱峰,泳道9为流出峰。 Figure 2 is the SDS-PAGE electrophoresis of the recombinant fusion expression product GST-AccRoyalisin through affinity separation. Wherein, lane M is the protein standard, lane M is the protein standard, lanes 3-7 are the elution peaks obtained from purification, and lane 9 is the elution peak.
图3为以重组GST-AccRoyalisin抗体为一抗,以纯化的重组GST-AccRoyalisin为标准抗原,经梯度稀释,采用Elisa法测定450 nm处的测吸光值。以吸光值OD450为纵坐标,GST-AccRoyalisin标准溶液浓度为横坐标,绘制成的标准曲线:y=0.017x+0.067,R2=0.998。 Figure 3 shows the absorbance at 450 nm measured by Elisa method using recombinant GST-AccRoyalisin antibody as primary antibody and purified recombinant GST-AccRoyalisin as standard antigen after serial dilution. Taking the absorbance value OD 450 as the ordinate, and the concentration of GST-AccRoyalisin standard solution as the abscissa, the standard curve drawn is: y=0.017x+0.067, R 2 =0.998.
图4为以GST-AccRoyalisin抗体为一抗,分别以中蜂和意蜂工蜂血淋巴为抗原,采用Elisa法测定两种蜜蜂血淋巴中Royalisin含量的结果比较。纵坐标为每μl蜜蜂血淋巴中的Royalisin含量,横坐标为蜜蜂接种大肠杆菌后的时间(小时)。 Figure 4 is a comparison of the results of determining the Royalisin content in the hemolymph of the two bees using the GST-AccRoyalisin antibody as the primary antibody and using the hemolymph of the Chinese bee and the Italian worker bee as antigens by using the Elisa method. The vertical axis is the Royalisin content per μl of bee hemolymph, and the horizontal axis is the time (hours) after the bees were inoculated with E. coli.
具体实施方式 Detailed ways
本发明公开了利用大肠杆菌重组表达的中华蜜蜂(Apis cerana cerana)王浆抗菌肽AccRoyalisin为抗原,免疫大白兔制备多克隆抗体,再以此多克隆抗体为一抗,以重组表达GST-AccRoyalisin为标准蛋白为抗原作倍比稀释,用酶标仪通过Elisa法,检测不同浓度GST-AccRoyalisin蛋白样品的吸光度,建立吸光度与GST-AccRoyalisin蛋白浓度的标准曲线。将不同蜂种或蜂群的血淋巴、蜂王浆冻干粉稀释,作为抗原,采用Elisa法检测获得样品吸光度,代入所建立的标准曲线,计算得到样品中的Royalisin的含量。 The invention discloses that the antibacterial peptide AccRoyalisin of royal jelly of Chinese bee ( Apis cerana cerana ) recombinantly expressed by Escherichia coli is used as an antigen to immunize white rabbits to prepare a polyclonal antibody, and then the polyclonal antibody is used as a primary antibody, and the recombinantly expressed GST-AccRoyalisin is used as a standard The protein was diluted as the antigen, and the absorbance of different concentrations of GST-AccRoyalisin protein samples was detected by Elisa method with a microplate reader, and a standard curve between absorbance and GST-AccRoyalisin protein concentration was established. The hemolymph and royal jelly freeze-dried powder of different bee species or bee colonies were diluted and used as antigens, and the absorbance of samples was detected by Elisa method, which was substituted into the established standard curve to calculate the content of Royalisin in the samples.
1、蜂王浆王浆抗菌肽AccRoyalisin抗体的制备方法和步骤、使用方法如下: 1. The preparation method, steps and usage of royal jelly antibacterial peptide AccRoyalisin antibody are as follows:
(1) 以含中华蜜蜂王浆抗菌肽AccRoyalisin 基因(GenBank 接受号: EF660337)的该蜂头部cDNA 文库质粒为模板, 用PCR 方法扩增出其前体片段, 并克隆入表达载体pGEX- 4T- 2 中,将筛选获得的重组pGEX-4T-2/ Accroyalisin转化大肠杆菌BL21中与谷胱甘肽( GST) 融合进行表达。中蜂王浆抗菌肽AccRoyalisin 和AccRoyalisin前体与西方蜜蜂抗菌肽AmRoyalisin前体的均由95个氨基酸残基组成,同源性为90%-92%;两者的成熟肽均由51个氨基酸残基组成,只有3-4个氨基酸残基不同,同源性在90%以上。
(1) Using the bee head cDNA library plasmid containing the AccRoyalisin gene (GenBank accession number: EF660337) as a template, its precursor fragment was amplified by PCR and cloned into the expression vector pGEX-4T-
对重组菌进行培养和诱导表达。细菌总蛋白经SDS-PAGE 电泳显示, 与含pGEX-4T-2 空载体的BL21 菌体相比, pGEX-4T-2/ Acc- royalisin 工程菌具有大小约36 ku 的特异性条带(图1) 。Acc-royalisin理论分子质量为5. 52 kDa, 加上pGEX-4T-2 载体中与其融合表达的、质量为26 kDa 的GST 蛋白, 预期GST-A ccRoyalisin 融合蛋白质量为31.2 kDa, 因此, 该特异性蛋白与其预期蛋白分子量相符. 进一步对重组表达产物进行超声波破碎和离心处理, 对获得的上清和沉淀分别进行SDS-PAGE电泳分析, 二者均显示出清晰的目的蛋白, 显示表达产物以可溶性蛋白和包涵体蛋白2 种形式存在,其中具有生物活性,可直接通过亲和纯析方法分离的可溶性蛋白占大部分。将此SDS-PAGE电泳胶上的GST-AccRoyalisin 融合蛋白的转印到硝酸纤维素膜,用GST抗体作Western blot 分析,显示特异性印迹。 The recombinant bacteria were cultured and induced to express. The total bacterial protein was electrophoresed by SDS-PAGE. Compared with the BL21 bacteria containing pGEX-4T-2 empty vector, the pGEX-4T-2/ Acc-royalisin engineering bacteria had a specific band of about 36 ku in size (Figure 1 ). The theoretical molecular mass of Acc-royalisin is 5.52 kDa, plus the GST protein with a mass of 26 kDa fused with it expressed in pGEX-4T-2 vector, the expected mass of GST-A ccRoyalisin fusion protein is 31.2 kDa, therefore, the specific The molecular weight of the target protein was consistent with that of the expected protein. The recombinant expression product was further subjected to ultrasonic crushing and centrifugation, and the obtained supernatant and precipitate were analyzed by SDS-PAGE electrophoresis. There are two forms of inclusion body protein and inclusion body protein, among which the soluble protein which has biological activity and can be directly separated by affinity purification method accounts for the majority. Transfer the GST-AccRoyalisin fusion protein on the SDS-PAGE electrophoresis gel to the nitrocellulose membrane, and use GST antibody for Western blot analysis, showing specific blot.
(2) 将筛选得到的含AccRoyalisin的重组菌接种LB液体培养基,37℃ IPTG诱导表达12小时。将500 mL菌液转移至离心管,离心10 min(5000 rpm,4 ℃),去上清,沉淀置于冰上。每1 mL原培养液用50 μL冰浴PBS完全悬浮沉淀。在冰上用超声波短时破碎细胞直至样品不黏稠。用超声破碎后的菌液于10,000 rpm,4 ℃离心10 min。小心地将上清转移至一个用冰预冷的干净小管中。细胞沉淀再用冰浴PBS完全悬浮(每1 mL原培养液用50 μL冰浴PBS)。 (2) Inoculate the screened AccRoyalisin-containing recombinant bacteria into LB liquid medium, and induce expression with IPTG at 37°C for 12 hours. Transfer 500 mL of bacterial liquid to a centrifuge tube, centrifuge for 10 min (5000 rpm, 4 °C), remove the supernatant, and place the pellet on ice. Use 50 μL of ice-bathed PBS for every 1 mL of the original culture solution to completely suspend the pellet. Cells were briefly disrupted by sonication on ice until the sample was not viscous. The sonicated bacterial solution was centrifuged at 10,000 rpm, 4°C for 10 min. Carefully transfer the supernatant to a clean, ice-cooled vial. The cell pellet was then completely suspended in ice-bathed PBS (50 μL ice-bathed PBS was used for every 1 mL of original culture medium).
通过连接于AKTA explorer 100的含GST抗体的亲和层析预装柱进行目标蛋白分离。以紫外A280 nm的吸收峰作为蛋白的检测工具。过柱前样品须离心或0.45 μm过滤器。样品太粘稠,可用结合缓冲液稀释。 Separation of target protein by affinity chromatography prepacked column with GST antibody connected to AKTA explorer 100. The absorption peak of UVA at 280 nm was used as a detection tool for protein. Samples must be centrifuged or 0.45 μm filter before passing through the column. Samples are too viscous and can be diluted with Binding Buffer.
操作时水与缓冲液须用高纯水,缓冲液须过0.45 μm过滤器,然后超声脱气。结合缓冲液注入到注射器或水泵管中,连接柱子和注射器防止空气进柱。移去柱底出口处的小头。用5倍柱床体积的结合缓冲液平衡柱子。用注射器或泵进样,建议进样流速:0.2-1 mL/min。用5-10倍柱体积结合缓冲液清洗柱子或者清洗至流出液中无紫外吸收峰,流速为1-2 mL/min。用5-10倍柱体积洗脱缓冲液洗脱,流速为1-2 mL/min。当洗脱峰出现时,收集洗脱液。 Water and buffer solution must use high-purity water during operation, and buffer solution must pass through a 0.45 μm filter, and then ultrasonically degassed. Inject the binding buffer into the syringe or pump tubing, and connect the column to the syringe to prevent air from entering the column. Remove the small plug at the outlet at the bottom of the column. Equilibrate the column with 5 bed volumes of binding buffer. Inject with a syringe or a pump, the recommended injection flow rate: 0.2-1 mL/min. Wash the column with 5-10 times column volume binding buffer or until there is no UV absorption peak in the effluent, and the flow rate is 1-2 mL/min. Elute with 5-10 column volumes of elution buffer at a flow rate of 1-2 mL/min. When the elution peak appears, collect the eluate.
取亲和分离的洗脱峰,作SDS-PAGE电泳分析,结果(见图2)显示,从图中洗脱峰和流出峰的蛋白电泳结果看,从该纯化体系得到的洗脱峰为分子量大小32 kDa左右的单一条带蛋白,与目的蛋白大小一致,表明纯化后得到单一目的蛋白。流出峰含有多条蛋白条带,属于混合蛋白,与峰形图一致。流出峰中同样有目的蛋白条带,说明部分目的蛋白未能及时与柱子结合而直接以流出液形式流出。 Take the elution peak of affinity separation and analyze it by SDS-PAGE electrophoresis. The result (see Figure 2) shows that the elution peak obtained from this purification system is the molecular weight A single band protein with a size of about 32 kDa is consistent with the size of the target protein, indicating that a single target protein was obtained after purification. The elution peak contains multiple protein bands, belonging to mixed proteins, which is consistent with the peak shape diagram. There are also target protein bands in the elution peak, indicating that part of the target protein fails to bind to the column in time and directly flows out in the form of effluent.
(3) 取经AKTA过柱纯化洗脱得到的GST-AccRoyalisin,装入透析袋中,透析过夜,将透析脱盐溶液液转入1.5 mL eppendorf管中,冷冻干燥,用0.9%的生理盐水溶解纯化的蛋白,作为抗原备用。 (3) Take the GST-AccRoyalisin purified and eluted by AKTA column, put it into a dialysis bag, dialyze overnight, transfer the dialysis desalted solution into a 1.5 mL eppendorf tube, freeze-dry, dissolve the purified GST-AccRoyalisin with 0.9% normal saline protein as an antigen.
2、多克隆抗体GST-AccRoyalisin制备 2. Preparation of polyclonal antibody GST-AccRoyalisin
选取14-16周龄的健康雄性家兔2只,采用皮下注射法,每只注射0.5 mL左右纯化的融合蛋白抗原。免疫前,从兔耳抽取血样,作为阴性对照。将融合蛋白抗原溶于700 μL生理盐水,加700 μL弗氏完全佐剂和适量青霉素、链霉素溶液乳化,皮下多点注射免疫。3周后,用同样的抗原和佐剂及青霉素乳化液,作一次加强免疫。5周后,融合蛋白抗原溶于1 mL生理盐水肌肉注射免疫; 6周后,再次用1 mL溶有融合蛋白抗原的生理盐水加强免疫。同时,从兔耳抽血样,采用间接ELISA方法进行多抗血清效价测定;7周后,颈动脉收集血液,置室温下使其凝固。将凝固的血液放入37 ℃温箱内半小时,再置4 ℃冰箱过夜,使血块收缩,抗血清析出;吸出抗血清,3,000 rpm离心10 min,吸上清液分装,-80 ℃保存备用。 Two healthy male rabbits aged 14-16 weeks were selected, and each rabbit was injected with about 0.5 mL of purified fusion protein antigen by subcutaneous injection. Before immunization, blood samples were drawn from rabbit ears as negative controls. The fusion protein antigen was dissolved in 700 μL of normal saline, emulsified with 700 μL of Freund’s complete adjuvant and appropriate amount of penicillin and streptomycin, and injected subcutaneously at multiple points for immunization. Three weeks later, a booster immunization was performed with the same antigen, adjuvant and penicillin emulsion. After 5 weeks, the fusion protein antigen was dissolved in 1 mL of normal saline for intramuscular injection; after 6 weeks, the immunization was boosted again with 1 mL of normal saline containing the fusion protein antigen. At the same time, blood samples were drawn from the rabbit ears, and the titer of multiple antiserum was determined by indirect ELISA; after 7 weeks, the blood was collected from the carotid artery and allowed to coagulate at room temperature. Put the coagulated blood in an incubator at 37°C for half an hour, then put it in a refrigerator at 4°C overnight to shrink the blood clot and precipitate the antiserum; suck out the antiserum, centrifuge at 3,000 rpm for 10 min, aspirate the supernatant and store at -80°C spare.
3、利用Elisa方法测定蜜蜂工蜂血淋巴中Royalisin 含量 3. Determination of Royalisin content in bee worker bee hemolymph by Elisa method
(3.1)包被:分别用权利要求1所述重组GST-AccRoyalisin作为抗原,用碳酸盐缓冲液(CBS,Na2CO3 1.59g,NaHCO3 2.93g,ddH2O 950 ml,调节pH值至9.6,加ddH2O定容至1000 ml,4℃保存)将10 μg/ml的AccRoyalisin标准蛋白溶液,按倍比梯度稀释法加样于96孔板,每孔加100 μl/孔,4℃包被过夜;
(3.1) Coating: use the recombinant GST-AccRoyalisin described in
(3.2)封闭:次日弃酶联板小孔中的包被液,以PBST(PBS+0.05% Tween-20)为洗涤液,每步洗涤5-10次,并拍干。然后加100 μL 含5% BSA或者脱脂奶粉的PBST溶液中37 ℃封闭1.5 h; (3.2) Blocking: Discard the coating solution in the wells of the enzyme-linked plate the next day, use PBST (PBS+0.05% Tween-20) as the washing solution, wash 5-10 times in each step, and pat dry. Then add 100 μL of PBST solution containing 5% BSA or skimmed milk powder to block at 37 °C for 1.5 h;
(3.3)弃酶联板小孔中的封闭液,并用PBST洗涤。加入一抗,用磷酸盐缓冲液(PBS,KH2PO4 0.27g,Na2HPO4 1.42g,NaCl 8g,KCl 0.2g,ddH2O 800mL,用浓盐酸调pH至7.4,ddH2O定容到1L)稀释1000倍,100uL/孔,37℃静置1-2 h; (3.3) Discard the blocking solution in the wells of the enzyme-linked plate and wash with PBST. Add primary antibody, use phosphate buffer solution (PBS, KH 2 PO 4 0.27g , Na 2 HPO 4 1.42g, NaCl 8g, KCl 0.2g, ddH 2 O 800mL, adjust pH to 7.4 with concentrated hydrochloric acid, volume to 1L), dilute 1000 times, 100uL/well, stand at 37°C for 1-2 h;
(3.4)洗涤:用自来水冲洗10次,拍干; (3.4) Washing: Rinse 10 times with tap water and pat dry;
(3.5)弃酶联板小孔中的一抗,并用PBST洗涤以HRP标记的羊抗兔IgG为二抗,稀释5000倍,100μl/孔,37℃静置1 h; (3.5) Discard the primary antibody in the small well of the enzyme-linked plate, and wash it with PBST. Use HRP-labeled goat anti-rabbit IgG as the secondary antibody, dilute 5000 times, 100 μl/well, and stand at 37°C for 1 hour;
(3.6)洗涤:用自来水冲洗10次,拍干; (3.6) Washing: Rinse 10 times with tap water and pat dry;
(3.7)液,50μl/孔,加完立即在酶标仪上测量波长450 nm的吸光值(450 nm为该显色剂的最大吸收波长); (3.7) solution, 50 μl/well, measure the absorbance value at a wavelength of 450 nm on a microplate reader immediately after adding (450 nm is the maximum absorption wavelength of the chromogen);
(3.8)用抗体检测得表1。以OD450吸光值平均值(n=3)为纵坐标,GST-AccRoyalisin标准蛋白溶液浓度为横坐标,得到标准曲线(图3):y = 0.017x + 0.067,R2=0.998。 (3.8) Table 1 was obtained by antibody detection. Taking the average OD 450 absorbance value (n=3) as the ordinate, and the concentration of GST-AccRoyalisin standard protein solution as the abscissa, the standard curve (Figure 3) was obtained: y = 0.017x + 0.067, R 2 =0.998.
表1 用GST-AccRoyalisin抗体测定梯度稀释标准多肽的得到的吸光度 Table 1 The absorbance obtained by measuring the gradient dilution standard polypeptide with GST-AccRoyalisin antibody
(3.9)采集蜜蜂和染菌处理 (3.9) Collection of bees and infection treatment
从养蜂场随机各挑一个中华密蜂和意大利蜜蜂蜂箱,分别巢脾,用广口瓶随机取100只左右工蜂。分为三组: Randomly pick a beehive of Apis chinensis and Apis mellifera from the apiary, respectively comb, and randomly take about 100 worker bees with jars. Divided into three groups:
不处理组:各取中蜂、意蜂工蜂30只。 No treatment group: 30 worker bees from Zhongfeng and Italian bees were taken respectively.
②各取中蜂、意蜂工蜂60只,用CO2麻醉后,每只工蜂在腹部注射50cfu/g 的大肠杆菌2 ul染菌, 然后置养虫笼内,用10%的蜂蜜水饲养,隔离24小时候回捕。 ② Take 60 worker bees of Chinese bees and Italian bees respectively. After being anesthetized with CO 2 , each worker bee is injected with 2 ul of Escherichia coli at 50 cfu/g in the abdomen, and then placed in insect cages and fed with 10% honey water. Recapture after 24 hours of isolation.
各取中蜂、意蜂工蜂60只,用CO2麻醉后,每只工蜂在腹部注射50 cfu/mL 的大肠杆菌2 ul染菌,然后置养虫笼内,用10%的蜂蜜水饲养,隔离48小时候回捕。 60 worker bees of Chinese bees and Italian bees were taken respectively. After being anesthetized with CO 2 , each worker bee was injected with 2 ul of Escherichia coli at 50 cfu/mL in the abdomen, and then placed in insect cages and fed with 10% honey water. Recapture after 48 hours of isolation.
(3.10)提取蜜蜂血淋巴 (3.10) Extraction of bee hemolymph
分别从上述三组蜜蜂中随机采集中蜂和意蜂15头,以5头蜜蜂为1个样本,各设3次重复。用剪刀切开蜜蜂颈部背面,让血淋巴自动涌出,用毛细管吸取,将收集的血淋巴加入离心管,同时加入微量苯基硫脲,防止血浆中苯酚基氧化酶活化使血淋巴黑化,离心除去血细胞。取上清备用。 A total of 15 Chinese bees and Italian bees were randomly collected from the above three groups of bees, and 5 bees were used as a sample, and 3 replicates were set for each. Cut the back of the bee’s neck with scissors, let the hemolymph flow out automatically, absorb it with a capillary tube, add the collected hemolymph to the centrifuge tube, and add a small amount of phenylthiourea at the same time to prevent the activation of phenol-based oxidase in the plasma and blacken the hemolymph , centrifuged to remove blood cells. Take the supernatant for later use.
(3.11)分别吸取中蜂和意蜂血淋巴10 uL,加入PBS 990 uL,摇匀,配成浓度为10 μg/ml的溶液,每孔加100 uL/孔。按以上Elisa方法,分别测定中蜂和意蜂血淋巴的吸光值(OD450)值,结果见表3。将各吸光值代入实施例4中的标准曲线y = 0.017x + 0.067的Y项,换算得到血淋巴中抗菌肽含量含量(X )。
(3.11)
表2 用GST-AccRoyalisin抗体测定中蜂和意蜂血淋巴中抗菌肽含量结果 Table 2 The results of the determination of antimicrobial peptides in the hemolymph of Chinese bee and Italian bee by GST-AccRoyalisin antibody
将表2结果作t检验,并作图分析(图4),结果显示中蜂血淋巴中抗菌肽含量在接菌前、接菌24小时后和48小时后均极显著地高于意蜂(p<0.01)。表明中蜂对致病菌的抗病免疫力高于意蜂。同时,接菌免疫24小时后和48小时后,中蜂和意蜂血淋巴中的抗菌肽含量均显著提高,表现出明显的免疫应答。且中蜂的免疫应答比意蜂强。这对之前国内学者(Xu, P., et al. PLoS ONE. 2009, 4:1-9.)关于中蜂西方抗菌肽能力高于意蜂的报道作了很好的验证。因此,GST-AccRoyalisin抗体适合于评价蜂种和蜂群的抗病力。 The results in Table 2 were used for t-test and plotted for analysis (Figure 4). The results showed that the antimicrobial peptide content in the hemolymph of the Chinese bee was significantly higher than that of the Italian bee ( p <0.01). It shows that the resistance immunity of Chinese bees to pathogenic bacteria is higher than that of Italian bees. At the same time, after 24 hours and 48 hours after immunization, the content of antimicrobial peptides in the hemolymph of Zhongfeng and Italian bee were significantly increased, showing an obvious immune response. And the immune response of Chinese bees is stronger than that of Italian bees. This is a good verification of the previous domestic scholars (Xu, P., et al. PLoS ONE. 2009, 4:1-9.) report that the antimicrobial peptide ability of Chinese bee is higher than that of Italian bee. Therefore, the GST-AccRoyalisin antibody is suitable for evaluating the disease resistance of bee species and bee colonies.
4、利用Elisa间接法测定蜂王浆中Royalisin的含量 4. Determination of Royalisin content in royal jelly by Elisa indirect method
称取蜂王浆冻干粉1.5 mg,用1 ml PBS溶解,摇匀,配成浓度为1.5 mg/ml的溶液,经高速离心,取上清为抗原,稀释10倍,加样于96孔板,每孔加10 uL/孔,按以上Elisa方法,用GST-AccRoyalisin抗体作为一抗,测定吸光值(OD450)值,结果见表3。将各吸光值代入标准曲线y = 0.017x + 0.067的Y项,换算得到蜂王浆冻干粉中抗菌肽平均含量(X )为0.49±0.23μg/μL,即100×0.49/15=3.3%。 Weigh 1.5 mg of royal jelly freeze-dried powder, dissolve in 1 ml of PBS, shake well, make a solution with a concentration of 1.5 mg/ml, centrifuge at high speed, take the supernatant as the antigen, dilute 10 times, add the sample to a 96-well plate, Add 10 uL/well to each well, according to the above Elisa method, use GST-AccRoyalisin antibody as the primary antibody, and measure the absorbance value (OD 450 ). The results are shown in Table 3. Substituting each absorbance value into the Y item of the standard curve y = 0.017x + 0.067, the average content (X) of antimicrobial peptides in the royal jelly freeze-dried powder is converted to 0.49±0.23 μg/μL, that is, 100×0.49/15=3.3%.
表3 蜂王浆中Royalisin的含量测定结果(n=3) Table 3 Determination results of Royalisin in royal jelly (n=3)
下面结合具体实施例和附图,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明范围。 The present invention will be further described below in conjunction with specific embodiments and accompanying drawings. It should be understood that these examples are only used to illustrate the present invention and not to limit the scope of the present invention.
实施例1 AccRoyalisin基因的重组表达及融合表达产物的分离纯化Example 1 Recombinant expression of AccRoyalisin gene and separation and purification of fusion expression product
1. AccRoyalisin基因的重组表达和鉴定1. Recombinant expression and identification of AccRoyalisin gene
以含中华蜜蜂王浆抗菌肽AccRoyalisin 基因(GenBank 接受号: EF660337)的该蜂头部cDNA 文库质粒为模板, 用PCR 方法扩增出其前体片段, 并克隆入表达载体pGEX- 4T- 2 中,将筛选获得的重组pGEX-4T-2/ Accroyalisin转化大肠杆菌BL21中与谷胱甘肽( GST) 融合进行表达。中蜂王浆抗菌肽AccRoyalisin 和AccRoyalisin前体与西方蜜蜂抗菌肽AmRoyalisin前体的均由95个氨基酸残基组成,同源性为90%-92%;两者的成熟肽均由51个氨基酸残基组成,只有3-4个氨基酸残基不同,同源性在90%以上。 Using the bee head cDNA library plasmid containing the antibacterial peptide AccRoyalisin gene of Apis cerana royal jelly (GenBank acceptance number: EF660337) as a template, its precursor fragment was amplified by PCR and cloned into the expression vector pGEX-4T-2, The recombinant pGEX-4T-2/ Accroyalisin obtained by screening was transformed into Escherichia coli BL21 and fused with glutathione (GST) for expression. Both royal jelly antimicrobial peptide AccRoyalisin and AccRoyalisin precursor and Apis mellifera antimicrobial peptide AmRoyalisin precursor are composed of 95 amino acid residues, with a homology of 90%-92%; both mature peptides are composed of 51 amino acid residues , only 3-4 amino acid residues are different, and the homology is above 90%.
对重组菌进行培养和诱导表达。细菌总蛋白经SDS-PAGE 电泳显示, 与含pGEX-4T-2 空载体的BL21 菌体相比, pGEX-4T-2/ Acc- royalisin 工程菌具有大小约36 ku 的特异性条带(图1) 。Acc-royalisin理论分子质量为5. 52 kDa, 加上pGEX-4T-2 载体中与其融合表达的、质量为26 kDa 的GST 蛋白, 预期GST-A ccRoyalisin 融合蛋白质量为31.2 kDa, 因此, 该特异性蛋白与其预期蛋白分子量相符. 进一步对重组表达产物进行超声波破碎和离心处理, 对获得的上清和沉淀分别进行SDS-PAGE电泳分析, 二者均显示出清晰的目的蛋白, 显示表达产物以可溶性蛋白和包涵体蛋白2 种形式存在,其中具有生物活性,可直接通过亲和纯析方法分离的可溶性蛋白占大部分。将此SDS-PAGE电泳胶上的GST-AccRoyalisin 融合蛋白的转印到硝酸纤维素膜,用GST抗体作Western blot 分析,显示特异性印迹。 The recombinant bacteria were cultured and induced to express. The total bacterial protein was electrophoresed by SDS-PAGE. Compared with the BL21 bacteria containing pGEX-4T-2 empty vector, the pGEX-4T-2/ Acc-royalisin engineering bacteria had a specific band of about 36 ku in size (Figure 1 ). The theoretical molecular mass of Acc-royalisin is 5.52 kDa, plus the GST protein with a mass of 26 kDa fused with it expressed in pGEX-4T-2 vector, the expected mass of GST-A ccRoyalisin fusion protein is 31.2 kDa, therefore, the specific The molecular weight of the target protein was consistent with that of the expected protein. The recombinant expression product was further subjected to ultrasonic crushing and centrifugation, and the obtained supernatant and precipitate were analyzed by SDS-PAGE electrophoresis. There are two forms of inclusion body protein and inclusion body protein, among which the soluble protein which has biological activity and can be directly separated by affinity purification method accounts for the majority. Transfer the GST-AccRoyalisin fusion protein on the SDS-PAGE electrophoresis gel to the nitrocellulose membrane, and use GST antibody for Western blot analysis, showing specific blot.
2.重组融合表达产物GST-AccRoyalisin的亲和分离 2. Affinity separation of recombinant fusion expression product GST-AccRoyalisin
将筛选得到的含AccRoyalisin的重组菌接种LB液体培养基,37℃ IPTG诱导表达12小时。将500 mL菌液转移至离心管,离心10 min(5000 rpm,4 ℃),去上清,沉淀置于冰上。每1 mL原培养液用50 μL冰浴PBS完全悬浮沉淀。在冰上用超声波短时破碎细胞直至样品不黏稠。用超声破碎后的菌液于10,000 rpm,4 ℃离心10 min。小心地将上清转移至一个用冰预冷的干净小管中。细胞沉淀再用冰浴PBS完全悬浮(每1 mL原培养液用50 μL冰浴PBS)。 The screened AccRoyalisin-containing recombinant bacteria were inoculated into LB liquid medium, and the expression was induced by IPTG at 37°C for 12 hours. Transfer 500 mL of bacterial liquid to a centrifuge tube, centrifuge for 10 min (5000 rpm, 4 °C), remove the supernatant, and place the pellet on ice. Use 50 μL of ice-bathed PBS for every 1 mL of the original culture solution to completely suspend the pellet. Cells were briefly disrupted by sonication on ice until the sample was not viscous. The sonicated bacterial solution was centrifuged at 10,000 rpm, 4°C for 10 min. Carefully transfer the supernatant to a clean, ice-cooled vial. The cell pellet was then completely suspended in ice-bathed PBS (50 μL ice-bathed PBS was used for every 1 mL of original culture medium).
通过连接于AKTA explorer 100的含GST抗体的亲和层析预装柱进行目标蛋白分离。其原理是:目的蛋白带GST标签,在平衡缓冲液环境下能与GST亲和柱结合,不含GST标签的蛋白会被以流出峰的形式被洗脱。洗脱时,收集得到的洗脱液就是纯化的单一目的蛋白的盐溶液。以紫外A280 nm的吸收峰作为蛋白的检测工具。过柱前样品须离心或0.45 μm过滤器。样品太粘稠,可用结合缓冲液稀释。 Separation of target protein by affinity chromatography prepacked column with GST antibody connected to AKTA explorer 100. The principle is: the target protein has a GST tag and can bind to the GST affinity column in an equilibrium buffer environment, and the protein without the GST tag will be eluted in the form of an elution peak. During elution, the collected eluent is the salt solution of the purified single target protein. The absorption peak of UVA at 280 nm was used as a detection tool for protein. Samples must be centrifuged or 0.45 μm filter before passing through the column. Samples are too viscous and can be diluted with Binding Buffer.
操作时水与缓冲液须用高纯水,缓冲液须过0.45 μm过滤器,然后超声脱气。结合缓冲液注入到注射器或水泵管中,连接柱子和注射器防止空气进柱。移去柱底出口处的小头。用5倍柱床体积的结合缓冲液平衡柱子。用注射器或泵进样,建议进样流速:0.2-1 mL/min。用5-10倍柱体积结合缓冲液清洗柱子或者清洗至流出液中无紫外吸收峰,流速为1-2 mL/min。用5-10倍柱体积洗脱缓冲液洗脱,流速为1-2 mL/min。当洗脱峰出现时,收集洗脱液。 Water and buffer solution must use high-purity water during operation, and buffer solution must pass through a 0.45 μm filter, and then ultrasonically degassed. Inject the binding buffer into the syringe or pump tubing, and connect the column to the syringe to prevent air from entering the column. Remove the small plug at the outlet at the bottom of the column. Equilibrate the column with 5 bed volumes of binding buffer. Inject with a syringe or a pump, the recommended injection flow rate: 0.2-1 mL/min. Wash the column with 5-10 times column volume binding buffer or until there is no UV absorption peak in the effluent, and the flow rate is 1-2 mL/min. Elute with 5-10 column volumes of elution buffer at a flow rate of 1-2 mL/min. When the elution peak appears, collect the eluate.
取亲和分离的洗脱峰,作SDS-PAGE电泳分析,结果(见图2)显示,从图中洗脱峰和流出峰的蛋白电泳结果看,从该纯化体系得到的洗脱峰为分子量大小32 kDa左右的单一条带蛋白,与目的蛋白大小一致,表明纯化后得到单一目的蛋白。流出峰含有多条蛋白条带,属于混合蛋白,与峰形图一致。流出峰中同样有目的蛋白条带,说明部分目的蛋白未能及时与柱子结合而直接以流出液形式流出。 Take the elution peak of affinity separation and analyze it by SDS-PAGE electrophoresis. The result (see Figure 2) shows that the elution peak obtained from this purification system is the molecular weight A single band protein with a size of about 32 kDa is consistent with the size of the target protein, indicating that a single target protein was obtained after purification. The elution peak contains multiple protein bands, belonging to mixed proteins, which is consistent with the peak shape diagram. There are also target protein bands in the elution peak, indicating that part of the target protein fails to bind to the column in time and directly flows out in the form of effluent.
实施例2 GST-AccRoyalisin多克隆抗体制备Example 2 Preparation of GST-AccRoyalisin polyclonal antibody
取经AKTA过柱纯化洗脱得到的GST-AccRoyalisin,装入透析袋中,透析过夜,将透析脱盐溶液液转入1.5 mL eppendorf管中,冷冻干燥,用0.9%的生理盐水溶解纯化的蛋白,作为抗原备用。 Take the GST-AccRoyalisin purified and eluted by AKTA column, put it into a dialysis bag, dialyze overnight, transfer the dialysis desalted solution into a 1.5 mL eppendorf tube, freeze-dry, dissolve the purified protein with 0.9% normal saline, and use as Antigen back up.
选取14-16周龄的健康雄性家兔2只,采用皮下注射法,每只注射0.5 mL左右纯化的融合蛋白抗原。免疫前,从兔耳抽取血样,作为阴性对照。将融合蛋白抗原溶于700 μL生理盐水,加700 μL弗氏完全佐剂和适量青霉素、链霉素溶液乳化,皮下多点注射免疫。3周后,用同样的抗原和佐剂及青霉素乳化液,作一次加强免疫。5周后,融合蛋白抗原溶于1 mL生理盐水肌肉注射免疫; 6周后,再次用1 mL溶有融合蛋白抗原的生理盐水加强免疫。同时,从兔耳抽血样,采用间接ELISA方法进行多抗血清效价测定;7周后,颈动脉收集血液,置室温下使其凝固。将凝固的血液放入37 ℃温箱内半小时,再置4 ℃冰箱过夜,使血块收缩,抗血清析出;吸出抗血清,3,000 rpm离心10 min,吸上清液分装,-80 ℃保存备用。 Two healthy male rabbits aged 14-16 weeks were selected, and each rabbit was injected with about 0.5 mL of purified fusion protein antigen by subcutaneous injection. Before immunization, blood samples were drawn from rabbit ears as negative controls. The fusion protein antigen was dissolved in 700 μL of normal saline, emulsified with 700 μL of Freund’s complete adjuvant and appropriate amount of penicillin and streptomycin, and injected subcutaneously at multiple points for immunization. Three weeks later, a booster immunization was performed with the same antigen, adjuvant and penicillin emulsion. After 5 weeks, the fusion protein antigen was dissolved in 1 mL of normal saline for intramuscular injection; after 6 weeks, the immunization was boosted again with 1 mL of normal saline containing the fusion protein antigen. At the same time, blood samples were drawn from the rabbit ears, and the titer of multiple antiserum was determined by indirect ELISA; after 7 weeks, the blood was collected from the carotid artery and allowed to coagulate at room temperature. Put the coagulated blood in an incubator at 37°C for half an hour, then put it in a refrigerator at 4°C overnight to shrink the blood clot and precipitate the antiserum; suck out the antiserum, centrifuge at 3,000 rpm for 10 min, aspirate the supernatant and store at -80°C spare.
实施例3 Elisa法检测GST-AccRoyalisin多克隆抗体效价Example 3 Elisa method to detect GST-AccRoyalisin polyclonal antibody titer
用实施例1所分离的重组GST-AccRoyalisin为抗原,以实施例2制备的GST-AccRoyalisin抗体为一抗,按以下步骤操作: Using the recombinant GST-AccRoyalisin isolated in Example 1 as the antigen, and the GST-AccRoyalisin antibody prepared in Example 2 as the primary antibody, follow the steps below:
(1)包被:分别用实施例1所述重组GST-AccRoyalisin作为抗原,用碳酸盐缓冲液(CBS,Na2CO3 1.59g,NaHCO3 2.93g,ddH2O 950 ml,调节pH值至9.6,加ddH2O定容至1000 ml,4℃保存)稀释为1 μg/ml,100 μl/孔加入96孔板中,4℃过夜; (1) Coating: use the recombinant GST-AccRoyalisin described in Example 1 as the antigen, adjust the pH value with carbonate buffer (CBS, Na 2 CO 3 1.59 g, NaHCO 3 2.93 g, ddH 2 O 950 ml to 9.6, add ddH 2 O to 1000 ml, store at 4°C), dilute to 1 μg/ml, add 100 μl/well into a 96-well plate, and store at 4°C overnight;
(2)封闭:次日弃酶联板小孔中的包被液,以PBST(PBS+0.05% Tween-20)为洗涤液,每步洗涤5-10次,并拍干。然后加100 μL 含5% BSA或者脱脂奶粉的PBST溶液中37 ℃封闭1.5 h。 (2) Blocking: Discard the coating solution in the small wells of the enzyme-linked plate the next day, use PBST (PBS+0.05% Tween-20) as the washing solution, wash 5-10 times in each step, and pat dry. Then add 100 μL of PBST solution containing 5% BSA or skimmed milk powder to block for 1.5 h at 37 °C.
(3)弃酶联板小孔中的封闭液,并用PBST洗涤。加入一抗,用磷酸盐缓冲液(PBS,KH2PO4 0.27g,Na2HPO4 1.42g,NaCl 8g,KCl 0.2g,ddH2O 800mL,用浓盐酸调pH至7.4,ddH2O定容到1L)稀释1000倍,100uL/孔,37℃静置1-2 h。 阴性对照与阳性抗血清同样比例稀释。设不加一抗的空白对照组。 (3) Discard the blocking solution in the small wells of the enzyme-linked plate, and wash with PBST. Add primary antibody, use phosphate buffer solution (PBS, KH 2 PO 4 0.27g , Na 2 HPO 4 1.42g, NaCl 8g, KCl 0.2g, ddH 2 O 800mL, adjust pH to 7.4 with concentrated hydrochloric acid, Volume to 1L) was diluted 1000 times, 100uL/well, and stood at 37°C for 1-2 h. The negative control was diluted in the same ratio as the positive antiserum. A blank control group without primary antibody was set up.
(4)洗涤:用自来水冲洗10次,拍干。 (4) Washing: Rinse 10 times with tap water and pat dry.
(5)弃酶联板小孔中的一抗,并用PBST洗涤以HRP标记的羊抗兔IgG为二抗,稀释5000倍,100μl/孔,37℃静置1 h。 (5) Discard the primary antibody in the wells of the enzyme-linked plate and wash it with PBST. Use HRP-labeled goat anti-rabbit IgG as the secondary antibody, dilute it 5000 times, 100 μl/well, and let stand at 37°C for 1 h.
(6)洗涤:用自来水冲洗10次,拍干; (6) Washing: Rinse 10 times with tap water and pat dry;
(7)以TMB为显色底物,100 μl/孔,37℃放置15 min;以2 M H2SO4为终止液,50μl/孔,加完立即在酶标仪上测量波长450 nm的吸光值。450 nm为该显色剂的最大吸收波长。
(7) Use TMB as the chromogenic substrate, 100 μl/well, place at 37°C for 15 minutes;
(8)求出样品OD值的平均值P,阴性对照OD值N,若P≥2N,则视为阳性反应,否则为阴性反应。 (8) Calculate the average value P of the OD value of the sample, and the OD value N of the negative control. If P≥2N, it is regarded as a positive reaction, otherwise it is a negative reaction.
根据表4测定结果表明,所制备的GST-AccRoyalisin多克隆效价高于40000倍。 According to the measurement results in Table 4, it shows that the polyclonal potency of the prepared GST-AccRoyalisin is higher than 40000 times.
表4 Elisa 测定GST-AccRoyalisin多克隆抗体对标准多肽的效价(n=6) Table 4 The potency of GST-AccRoyalisin polyclonal antibody against standard peptides determined by Elisa (n=6)
p<0.00001,**:表示与对照相比有极显著差异p<0.01 p< 0.00001, **: means there is a very significant difference compared with the control p<0.01
实施例4 AccRoyalisin标准曲线的建立
将亲和分离得到的GST-AccRoyalisin标准蛋白溶于CBS中,配成10 μg/ml的溶液。将GST-AccRoyalisin多克隆抗体按1: 1000的比例稀释,作为一抗;以HRP标记的羊抗兔IgG为酶标二抗,按1: 5000加入PBS中,配成二抗溶液。 Dissolve the GST-AccRoyalisin standard protein obtained by affinity separation in CBS to make a 10 μg/ml solution. The GST-AccRoyalisin polyclonal antibody was diluted at a ratio of 1:1000 as the primary antibody; HRP-labeled goat anti-rabbit IgG was used as the enzyme-labeled secondary antibody, which was added to PBS at a ratio of 1:5000 to form a secondary antibody solution.
将10 μg/ml的AccRoyalisin标准蛋白溶液,按倍比梯度稀释法加样于96孔板,每孔加100 μl/孔,4℃包被过夜。弃孔中液体,用PBST缓冲液洗5遍,以200 μl/孔的量加入脱脂牛奶封闭液,37℃封闭1.5 h。弃脱脂牛奶封闭液,用PBST缓冲液洗5遍,以100 μl/孔的量,分别加入一抗抗体、二抗抗体溶液,37℃反应1 h。弃一抗溶液,用PBST缓冲液洗涤5次,以100 μl/孔的量加入二抗溶液,37℃反应0.5 h。弃二抗溶液,用PBST缓冲液洗涤5次,以100 μl/孔的量加入显色液TMB,37℃反应15 min,以50μl/孔的量加TMB终止液2M H2SO4。立即置于酶标仪上,测定450 nm处的测吸光值。
Add 10 μg/ml AccRoyalisin standard protein solution to a 96-well plate by doubling gradient dilution method, add 100 μl/well to each well, and coat overnight at 4°C. The liquid in the wells was discarded, washed 5 times with PBST buffer, and skimmed milk blocking solution was added at 200 μl/well, and blocked at 37°C for 1.5 h. Discard the skimmed milk blocking solution, wash with
(1)用抗体检测得表1。以OD450吸光值平均值(n=3)为纵坐标,GST-AccRoyalisin标准蛋白溶液浓度为横坐标,得到标准曲线(图3):y = 0.017x + 0.067,R2=0.998。 (1) Table 1 was obtained by antibody detection. Taking the average OD 450 absorbance value (n=3) as the ordinate, and the concentration of GST-AccRoyalisin standard protein solution as the abscissa, the standard curve (Figure 3) was obtained: y = 0.017x + 0.067, R 2 =0.998.
表1 用GST-AccRoyalisin抗体测定梯度稀释标准多肽的得到的吸光度 Table 1 The absorbance obtained by measuring the gradient dilution standard polypeptide with GST-AccRoyalisin antibody
实施例5 蜜蜂工蜂血淋巴中Royalisin 含量的Elisa测定Example 5 Elisa determination of Royalisin content in bee worker bee hemolymph
1. 蜜蜂的取样、免疫处理和血淋巴提取1. Sampling, Immunization Processing, and Hemolymph Extraction of Honey Bees
(1)采集蜜蜂和染菌处理(1) Collection of bees and infection treatment
从养蜂场随机各挑一个中华密蜂和意大利蜜蜂蜂箱,分别巢脾,用广口瓶随机取100只左右工蜂。分为三组: Randomly pick a beehive of Apis chinensis and Apis mellifera from the apiary, respectively comb, and randomly take about 100 worker bees with jars. Divided into three groups:
不处理组:各取中蜂、意蜂工蜂30只。 No treatment group: 30 worker bees from Zhongfeng and Italian bees were taken respectively.
②各取中蜂、意蜂工蜂60只,用CO2麻醉后,每只工蜂在腹部注射50cfu/g 的大肠杆菌2 ul染菌, 然后置养虫笼内,用10%的蜂蜜水饲养,隔离24小时候回捕。 ② Take 60 worker bees of Chinese bees and Italian bees respectively. After being anesthetized with CO 2 , each worker bee is injected with 2 ul of Escherichia coli at 50 cfu/g in the abdomen, and then placed in insect cages and fed with 10% honey water. Recapture after 24 hours of isolation.
各取中蜂、意蜂工蜂60只,用CO2麻醉后,每只工蜂在腹部注射50 cfu/mL 的大肠杆菌2 ul染菌,然后置养虫笼内,用10%的蜂蜜水饲养,隔离48小时候回捕。 60 worker bees of Chinese bees and Italian bees were taken respectively. After being anesthetized with CO 2 , each worker bee was injected with 2 ul of Escherichia coli at 50 cfu/mL in the abdomen, and then placed in insect cages and fed with 10% honey water. Recapture after 48 hours of isolation.
(2)提取蜜蜂血淋巴(2) Extraction of bee hemolymph
分别从上述三组蜜蜂中随机采集中蜂和意蜂15头,以5头蜜蜂为1个样本,各设3次重复。用剪刀切开蜜蜂颈部背面,让血淋巴自动涌出,用毛细管吸取,将收集的血淋巴加入离心管,同时加入微量苯基硫脲,防止血浆中苯酚基氧化酶活化使血淋巴黑化,离心除去血细胞。取上清备用。 A total of 15 Chinese bees and Italian bees were randomly collected from the above three groups of bees, and 5 bees were used as a sample, and 3 replicates were set for each. Cut the back of the bee’s neck with scissors, let the hemolymph flow out automatically, absorb it with a capillary tube, add the collected hemolymph into the centrifuge tube, and add a small amount of phenylthiourea at the same time to prevent the activation of phenol-based oxidase in the plasma and blacken the hemolymph , centrifuged to remove blood cells. Take the supernatant for later use.
2.用GST-AccRoyalisin多克隆抗体测定中蜂和意蜂血清中抗菌肽含量2. Determination of Antimicrobial Peptide Content in Serum of Chinese Bee and Italian Bee with GST-AccRoyalisin Polyclonal Antibody
分别吸取中蜂和意蜂血淋巴10 uL,加入PBS 990 uL,摇匀,配成浓度为10 μg/ml的溶液,每孔加100 uL/孔。按以上Elisa方法,分别测定中蜂和意蜂血淋巴的吸光值(OD450)值,结果见表2。将各吸光值代入实施例4中的标准曲线y = 0.017x + 0.067的Y项,换算得到血淋巴中抗菌肽含量含量(X )。
表2 用GST-AccRoyalisin抗体测定中蜂和意蜂血淋巴中抗菌肽含量结果 Table 2 The results of the determination of antimicrobial peptides in the hemolymph of Chinese bee and Italian bee by GST-AccRoyalisin antibody
将表2结果作t检验,并作图分析(图4),结果显示中蜂血淋巴中抗菌肽含量在接菌前、接菌24小时后和48小时后均极显著地高于意蜂(p<0.01)。表明中蜂对致病菌的抗病免疫力高于意蜂。同时,接菌免疫24小时后和48小时后,中蜂和意蜂血淋巴中的抗菌肽含量均显著提高,表现出明显的免疫应答。且中蜂的免疫应答比意蜂强。这对之前国内学者(Xu, P., et al. PLoS ONE. 2009, 4:1-9.)关于中蜂西方抗菌肽能力高于意蜂的报道作了很好的验证。因此,GST-AccRoyalisin抗体适合于评价蜂种和蜂群的抗病力。 The results in Table 2 were used for t-test and plotted for analysis (Figure 4). The results showed that the antimicrobial peptide content in the hemolymph of the Chinese bee was significantly higher than that of the Italian bee ( p <0.01). It shows that the resistance immunity of Chinese bees to pathogenic bacteria is higher than that of Italian bees. At the same time, after 24 hours and 48 hours after inoculation, the content of antimicrobial peptides in the hemolymph of Zhongfeng and Italian bee were significantly increased, showing an obvious immune response. And the immune response of Chinese bees is stronger than that of Italian bees. This is a good verification of the previous domestic scholars (Xu, P., et al. PLoS ONE. 2009, 4:1-9.) report that the antimicrobial peptide ability of Chinese bee is higher than that of Italian bee. Therefore, the GST-AccRoyalisin antibody is suitable for evaluating the disease resistance of bee species and bee colonies.
实施例5 Elisa间接法定量测定蜂王浆中Royalisin的含量Example 5 Elisa indirect quantitative determination of the content of Royalisin in royal jelly
称取蜂王浆冻干粉1.5 mg,用1 ml PBS溶解,摇匀,配成浓度为1.5 mg/ml的溶液,经高速离心,取上清为抗原,稀释10倍,加样于96孔板,每孔加10 uL/孔,按以上Elisa方法,用GST-AccRoyalisin抗体作为一抗,测定吸光值(OD450)值,结果见表3。将各吸光值代入实施例4中的标准曲线y = 0.017x + 0.067的Y项,换算得到蜂王浆冻干粉中抗菌肽平均含量(X )为0.49±0.23μg/μL,即100×0.49/15=3.3%。 Weigh 1.5 mg of royal jelly freeze-dried powder, dissolve in 1 ml of PBS, shake well, make a solution with a concentration of 1.5 mg/ml, centrifuge at high speed, take the supernatant as the antigen, dilute 10 times, add the sample to a 96-well plate, Add 10 uL/well to each well, according to the above Elisa method, use GST-AccRoyalisin antibody as the primary antibody, and measure the absorbance value (OD 450 ). The results are shown in Table 3. Substituting each absorbance value into the Y item of the standard curve y=0.017x+0.067 in Example 4, the average content (X) of antimicrobial peptides in the royal jelly freeze-dried powder obtained by conversion is 0.49 ± 0.23 μg/μL, i.e. 100 × 0.49/15 =3.3%.
表3蜂王浆中Royalisin的含量测定结果(n=3) Table 3 Determination results of Royalisin in royal jelly (n=3)
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012105737208A CN103044549A (en) | 2012-12-26 | 2012-12-26 | Preparation method of apis cerana antimicrobial peptide AccRoyalisin polyclonal antibody and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012105737208A CN103044549A (en) | 2012-12-26 | 2012-12-26 | Preparation method of apis cerana antimicrobial peptide AccRoyalisin polyclonal antibody and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103044549A true CN103044549A (en) | 2013-04-17 |
Family
ID=48057431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012105737208A Pending CN103044549A (en) | 2012-12-26 | 2012-12-26 | Preparation method of apis cerana antimicrobial peptide AccRoyalisin polyclonal antibody and use thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103044549A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104316587A (en) * | 2014-10-20 | 2015-01-28 | 浙江大学 | Establishment method and application for detecting freshness of royal jelly by adopting running gel protein band |
CN111650143A (en) * | 2020-06-23 | 2020-09-11 | 成都欧林生物科技股份有限公司 | Detection method of GST residue in recombinant Staphylococcus aureus vaccine HI protein stock solution and GST protein standard and application |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101705231A (en) * | 2009-11-19 | 2010-05-12 | 浙江大学 | Apis cerana royal jelly antibacterial peptide AccRoyalisin gene and encoded polypeptide thereof and application thereof |
-
2012
- 2012-12-26 CN CN2012105737208A patent/CN103044549A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101705231A (en) * | 2009-11-19 | 2010-05-12 | 浙江大学 | Apis cerana royal jelly antibacterial peptide AccRoyalisin gene and encoded polypeptide thereof and application thereof |
Non-Patent Citations (3)
Title |
---|
《中国优秀硕士学位论文全文数据库 农业科技辑》 20110715 金凤 AccRoyalisin重组表达及产物抑菌活性研究 D051-4 , 第07期 * |
丁美会 等: "中华蜜蜂王浆抗菌肽Acc-royalisin 基因原核表达及多克隆抗体制备", 《浙江大学学报(农业与生命科学版)》 * |
金凤: "AccRoyalisin重组表达及产物抑菌活性研究", 《中国优秀硕士学位论文全文数据库 农业科技辑》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104316587A (en) * | 2014-10-20 | 2015-01-28 | 浙江大学 | Establishment method and application for detecting freshness of royal jelly by adopting running gel protein band |
CN111650143A (en) * | 2020-06-23 | 2020-09-11 | 成都欧林生物科技股份有限公司 | Detection method of GST residue in recombinant Staphylococcus aureus vaccine HI protein stock solution and GST protein standard and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Krijgsveld et al. | Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines | |
CN103695508B (en) | The fermentation of staphylococcus aureus HI recombiant protein and purifying process | |
CN105158480A (en) | Kit for detecting peste des petits ruminants virus hemagglutinin protein antibody and application method of kit | |
CN105602907A (en) | Infectious bronchitis virus resistance monoclonal antibodies | |
CN103059135A (en) | A specific antibody of major royal jelly protein MRJP1 and a preparation method thereof and Elisa quantitative detection thereof | |
CN103819557B (en) | A kind of Enterobacter sakazakii OmpA polyclonal antibody and preparation method thereof and application | |
CN103333225A (en) | Antibacterial peptide, preparation method and applications thereof | |
CN106556701A (en) | Brucella melitensis indirect ELISA antibody assay kit | |
CN106632664B (en) | Apolipoprotein II/I and preparation method, biological function and application thereof | |
CN105367632B (en) | Two kinds of s. aureus protein antigens and its preparation and application | |
CN103044549A (en) | Preparation method of apis cerana antimicrobial peptide AccRoyalisin polyclonal antibody and use thereof | |
CN104845981B (en) | Babesiamicrofti Bm1524 antigens and its application | |
CN102898511B (en) | Purification method in preparation of methicillin staphylococcus aureus-resistant recombinant genetic engineering vaccine candidate antigen I12C | |
CN103882051B (en) | A kind of ELISA method and detection kit detecting antibody against swine fever virus | |
CN109337853B (en) | Purification method of pseudomonas aeruginosa genetic engineering vaccine candidate antigen rExoU | |
CN111529686A (en) | Application of galectin-9 from mandarin fish in preparing bacteriostatic agent | |
CN105693855A (en) | Method for efficiently preparing Enterobacter sakazakii polyclonal antibody | |
CN109030830B (en) | Adhesin albumin A pd and its preparing the application in haemophilus parasuis indirect ELISA antibody assay kit | |
CN103361317A (en) | Macaque IFN-gamma (interferon-gamma) monoclonal antibody hybridoma as well as preparation method and application thereof | |
CN114034860A (en) | A kind of indirect ELISA detection method of Mycobacterium tuberculosis MTB39A protein antibody and its kit | |
Rizzo et al. | Revisiting Cryptococcus extracellular vesicles properties and their use as vaccine platforms | |
CN101348519A (en) | Preparation technology and application of rice field eel antimicrobial peptide | |
CN106353496A (en) | Brucella fluorescence polarization (FPA) detection kit | |
CN104845982B (en) | Babesiamicrofti Bm186 antigens and its application | |
CN115433686B (en) | Construction method and application of recombinant Pichia pastoris with death protein and channel catfish β-defensin genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130417 |